The International CAA Association (ICAAA) was founded in 2014 with the goal of improving scientific understanding, diagnosis, and treatment of cerebral amyloid angiopathy (CAA). The ICAAA is comprised of leading clinicians and scientists in the CAA field drawn from medical centers and universities around the world. The ICAAA organizes bi-annual scientific meetings of the international CAA community, collaborative research projects, and consensus guidelines, all aimed at improving the condition of individuals suffering from this increasingly recognized disease of the brain’s small blood vessels.
Massachusetts General Hospital / Harvard Medical School, Boston, MA, USA
Leiden University Medical Center, the Netherlands
Lille University, France
University of Calgary, Canada
Massachusetts General Hospital / Harvard Medical School, Boston, MA, USA
Leiden University Medical Center, the Netherlands
Rush University, Chicago, Il, USA
Radboud University, Nijmegen, the Netherlands
Elmi van Beelen
Sandra Fens
Email: office@caaforum.org
The 8th International CAA Conference in Perth last year was a great success! New insights were shared on iatrogenic and Dutch-type CAA, perivascular amyloid clearance, biomarker research, and more. View the photos now at https://caaforum.org/index.php/news-events/ #AmyloidAngiopathy #iCAAPerth2022
Very much looking forward to the scientific session 'From Bench to Bedside and Beyond: Modern Perspectives in Cerebral Amyloid Angiopathy' at #isc2023, with @SMGreenbergNeur
@a_charidimou
@Prof_Piazza and others.
SAVE THE DATE: On the 28th of April our first ECR event will take place! With @MariekeWermer and @AndyShih_Lab, who will be giving the first 'Yoda talks'. Stay tuned for more information and the sign-up sheet! #ECRnetworkCAA @iCAAassociation
International CAA Association All rights reserved. | Privacy statement | Disclaimer